Prophylactic Ribonucleic Acid Vaccines to Combat RNA Viral Infections in Humans

Vaccines have evolved as widely applicable and available prophylaxes against infectious diseases. Advances in ribonucleic acid technologies revolutionized the biopharmaceutical field of vaccine manufacturing. Numerous novel mRNA-based vaccines that have been approved by the United States and Europea...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Louis, Irina Vlasova-St., Abadie, Jude
Formato: Capítulo de libro
Lenguaje:inglés
Publicado: IntechOpen 2022
Materias:
Acceso en línea:https://www.intechopen.com/chapters/84092
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!